Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases

Chemically modified mRNA represents a unique, efficient, and straightforward approach to produce a class of biopharmaceutical agents. It has been already approved as a vaccination-based method for targeting SARS-CoV-2 virus. The COVID-19 pandemic has highlighted the prospect of synthetic modified mR...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dana Elkhalifa, Menatallah Rayan, Ahmed T. Negmeldin, Abdelbary Elhissi, Ashraf Khalil
Format: article
Langue:EN
Publié: Elsevier 2022
Sujets:
Accès en ligne:https://doaj.org/article/c6076e1d48364f71a038e371a6ff5c8c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!